QPPV.COM KNOWLEDGE ASSESSMENT

Signal Detection in Pharmacovigilance

Test your understanding of the concepts covered by Signal Detection in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the principal purpose of periodic review of thresholds and detection methodologies?

To change thresholds whenever a signal is detected To ensure that methods remain scientifically justified, appropriate and effective as products, data and experience change To eliminate the need for medical review To ensure that the number of detected signals remains constant each year

Question 2 of 10 Which statement best explains why both false positives and false negatives are inherent risks in signal detection?

Pharmacovigilance databases contain only confirmed causal relationships Observed reporting patterns are affected by chance, bias, under-reporting, missing data and confounding Statistical methods always produce identical results across databases Medical review can identify every true safety concern without uncertainty

Question 3 of 10 Which finding should generally receive the highest priority for rapid escalation under the article's illustrative criteria?

A minimally elevated metric for a non-serious event with little medical plausibility A cluster of fatal or life-threatening events occurring within a short, temporally related period A historical association already well described in the product information A single non-serious report with a long delay and multiple alternative causes

Question 4 of 10 Which activity is most appropriately classified as validation rather than initial detection?

Running a disproportionality analysis across the safety database Identifying a cluster through literature monitoring Reviewing case details, time-to-onset, alternative causes and clinical plausibility to decide whether further assessment is warranted Setting the frequency of monthly database analyses

Question 5 of 10 A newly launched product has few reports and a rare but clinically severe event is suspected. Which approach is most appropriate?

Rely exclusively on disproportionality statistics because the event is rare Give particular weight to qualitative medical review and case-series assessment alongside quantitative monitoring Wait until the event reaches a large absolute number of reports Exclude the product from routine monitoring until its database is mature

Question 6 of 10 Which statement best describes the primary purpose of signal detection?

To establish that a product caused an adverse event To identify observations that may warrant validation and further assessment To determine whether a product's benefit-risk balance is definitively positive To replace individual case review with automated statistical analysis

Question 7 of 10 Why should social media and digital health data generally be used cautiously in signal detection?

They can never contain safety information Their data quality, representativeness, verification and interpretation may differ from established pharmacovigilance sources They are legally prohibited as a source of safety information They automatically provide reliable exposure denominators

Question 8 of 10 Why should numerical signal detection thresholds not be treated as universally fixed regulatory rules?

Because thresholds have no relationship to signal detection decisions Because organisations should justify approaches according to products, data sources, obligations and observed performance Because statistical thresholds are prohibited under GVP Module IX Because every product must use identical thresholds regardless of risk profile

Question 9 of 10 Which set of factors is most relevant when reviewing a case series for a potential signal?

Only the number of reports and the date of database entry Demographics, time-to-onset, outcomes, dose relationships, dechallenge or rechallenge, and alternative explanations Only whether the event appears in the product information Only the reporter's occupation and geographic location

Question 10 of 10 A company detects a candidate signal during a monthly run. Which record set would best demonstrate a complete and auditable process?

The monthly metric alone An email stating that the signal was discussed informally The source dataset and output, case review, validation rationale, SRC decision, QPPV involvement where applicable and documented closure or action Only the final regulatory submission, if one was made

Signal Detection in Pharmacovigilance

Cookie Settings